G. Atkinson

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study

L. Biasco, S. Galimberti, M. Valsecchi, 2019, The Lancet. Haematology.

Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation

P. Reinke, K. Schreeb, E. Culme-Seymour, 2022, Kidney international reports.

Feasibility of manufacture of chimeric antigen receptor-regulatory T cells from patients with end-stage renal disease

D. Cantarovich, K. Schreeb, E. Culme-Seymour, 2023, Translational Medicine Communications.

Open‐label randomized non‐inferiority trial of a fixed‐dose combination of glimepiride and atorvastatin for the treatment of people whose Type 2 diabetes is uncontrolled on metformin

A. Stylianou, P. Ambery, C. Dott, 2016, Diabetic medicine : a journal of the British Diabetic Association.